{"id":"NCT00424372","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia","officialTitle":"A LONG-TERM STUDY TO EVALUATE SAFETY AND EFFICACY STUDY OF PREGABALIN IN THE TREATMENT OF POSTHERPETIC NEURALGIA.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01-12","primaryCompletion":"2008-08-19","completion":"2008-08-19","firstPosted":"2007-01-19","resultsPosted":"2009-09-28","lastUpdate":"2021-08-27"},"enrollment":126,"design":{"allocation":"NON_RANDOMIZED","model":null,"masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Neuralgia, Postherpetic"],"interventions":[{"type":"DRUG","name":"pregabalin","otherNames":[]}],"arms":[{"label":"pregabalin","type":"EXPERIMENTAL"}],"summary":"To evaluate the safety of the long-term use of pregabalin.","primaryOutcome":{"measure":"Summary of Adverse Events","timeFrame":"52 weeks","effectByArm":[{"arm":"Pregabalin","deltaMin":124,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":33,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081121&StudyName=A%20Long-Term%20Study%20To%20Evaluate%20Safety%20And%20Efficacy%20Of%20Pregabalin%20For%20Postherpetic%20Neuralgia"]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":126},"commonTop":["Dizziness","Nasopharyngitis","Oedema peripheral","Somnolence","Weight increased"]}}